Related Experiment Video
Updated: Jan 4, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
A discovery platform for the identification of caloric restriction mimetics with broad health-improving effects
Oliver Kepp1,2,3, Guo Chen1,2,3,4, Didac Carmona-Gutierrez5
1Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France.
Abstract:
The age-related decline in organismal fitness results in vulnerability to pathologies and eventual lethal decay. One way to counteract cellular aging and to delay and/or prevent the onset of age-related maladies is the reduction of calorie intake or the institution of fasting regimens. Caloric restriction mimetics (CRMs) have the ability to imitate the health-promoting and lifespan-extending effects of caloric restriction without the need for dietary restriction. CRMs induce an increase in autophagic flux in response to the deacetylation of cellular proteins in the absence of cytotoxicity. Here we report the development of a high-throughput discovery platform for novel CRMs that uses systems biology approaches, in vitro validation and functional tests employing in vivo disease models. This workflow led to the identification of 3,4-dimethoxychalcone (3,4-DC) as a novel CRM that stimulated TFEB (transcription factor EB)- and TFE3 (transcription factor E3)-dependent macroautophagy/autophagy. 3,4-DC showed cardioprotective effects and stimulated anticancer immunosurveillance in the context of immunogenic chemotherapy.
Insights
Researchers identified a novel compound, 3,4-dimethoxychalcone (3,4-DC), that mimics caloric restriction benefits. This compound promotes cellular repair and shows potential in protecting the heart and enhancing cancer immunity.
Area of Science:
- Cellular Biology
- Aging Research
- Pharmacology
Background:
- Organismal aging leads to decreased fitness and increased disease susceptibility.
- Caloric restriction (CR) and fasting can counteract aging and extend lifespan.
- Caloric restriction mimetics (CRMs) offer CR benefits without dietary changes, promoting cellular health via increased autophagic flux.
Purpose of the Study:
- To develop a high-throughput platform for discovering novel CRMs.
- To identify compounds that imitate the health-promoting effects of caloric restriction.
- To validate CRM candidates using in vitro and in vivo models.
Main Methods:
- Utilized systems biology approaches for CRM discovery.
- Employed in vitro validation and functional tests.
- Tested candidate compounds in in vivo disease models.
Main Results:
- Identified 3,4-dimethoxychalcone (3,4-DC) as a novel CRM.
- 3,4-DC stimulates transcription factor EB (TFEB) and transcription factor E3 (TFE3)-dependent autophagy.
- Demonstrated cardioprotective effects and enhanced anticancer immunosurveillance of 3,4-DC.
Conclusions:
- A novel high-throughput platform successfully identified 3,4-DC as a CRM.
- 3,4-DC promotes autophagy and exhibits therapeutic potential in cardiovascular health and cancer immunotherapy.
Related Concept Videos
Regulation of Metabolism
Regulation of Food Intake

